Fetal surgery is one of medicine’s most delicate frontiers, but the procedure itself carries a hidden risk: it can trigger preterm birth. KOVE medical Ltd has raised $2.0M in a seed round to tackle that problem head-on.
The company is developing a solution aimed at reducing the risk of preterm birth following surgeries performed on a fetus during pregnancy. The fresh capital will help advance that work, though the company has not disclosed which investors participated in the round.
















.png&w=3840&q=75)

